https://www.globenewswire.com/news-release/2020/09/08/2089903/0/en/Synairgen-announces-positive-data-from-interim-analysis-of-SNG001-trial-in-COPD-patients.html Synairgen announces positive data from interim analysis of SNG001 trial in COPD patients
SNG001
A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza
https://clinicaltrials.gov/ct2/show/NCT03570359?type=Intr&cond=COPD&phase=01234&lupd_s=12%2F17%2F2018&lupd_d=14&sort=nwst A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza Condition : Chronic Obstructive Pulmonary Disease (COPD) Interventions : Drug: Interferon Beta-1A; Other: Placebo Sponsor : Synairgen Research Ltd. Recruiting NCT03570359 Wed, 27 Jun 2018 12:00:00 EDT
